L&G Healthcare Breakthrough UCITS ETF (GBP) | DOCGRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 65.7 | 0.1 | -33.3 | -2.8 | 2.1 | |
+/-Cat | 48.2 | -9.3 | -28.7 | 0.3 | -3.2 | |
+/-B’mrk | - | -18.1 | -39.2 | -0.3 | -6.0 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 24/04/2024 | GBX 884.10 | |
Day Change | -0.23% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 7855 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BK5BC677 | |
Fund Size (Mil) 24/04/2024 | USD 69.33 | |
Share Class Size (Mil) 24/04/2024 | USD 69.33 | |
Ongoing Charge 14/02/2024 | 0.49% |
Investment Objective: L&G Healthcare Breakthrough UCITS ETF (GBP) | DOCG |
The investment objective of the Fund is to provide exposure to the global healthcare technology industry. In order to achieve this investment objective, the Fund will seek to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 26/06/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
ROBO Gbl Healthcare Tech & Innov TR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for L&G Healthcare Breakthrough UCITS ETF (GBP) | DOCG | 24/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Staar Surgical Co | Healthcare | 2.59 |
Moderna Inc | Healthcare | 2.07 |
Boston Scientific Corp | Healthcare | 1.99 |
Natera Inc | Healthcare | 1.93 |
Diasorin SpA | Healthcare | 1.89 |
Increase Decrease New since last portfolio | ||
L&G Healthcare Breakthrough UCITS ETF (GBP) | DOCG |